Saturday, August 06, 2016 3:11:32 PM
West Pharmaceutical Services Inc. (WST) Sets New 12-Month High at $81.80
August 6th, 2016 - 0 comments - Filed Under - by Latisha Jones
West Pharmaceutical Services logoWest Pharmaceutical Services Inc. (NYSE:WST) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $81.80 and last traded at $81.80, with a volume of 97,633 shares traded. The stock had previously closed at $80.96.
A number of equities research analysts have issued reports on the stock. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Wednesday, April 20th. Jefferies Group reaffirmed a “hold” rating on shares of West Pharmaceutical Services in a research report on Thursday. Finally, Janney Montgomery Scott reaffirmed a “buy” rating and issued a $90.00 price objective (up from $69.00) on shares of West Pharmaceutical Services in a research report on Friday, May 13th.
August 6th, 2016 - 0 comments - Filed Under - by Latisha Jones
West Pharmaceutical Services logoWest Pharmaceutical Services Inc. (NYSE:WST) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $81.80 and last traded at $81.80, with a volume of 97,633 shares traded. The stock had previously closed at $80.96.
A number of equities research analysts have issued reports on the stock. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research report on Wednesday, April 20th. Jefferies Group reaffirmed a “hold” rating on shares of West Pharmaceutical Services in a research report on Thursday. Finally, Janney Montgomery Scott reaffirmed a “buy” rating and issued a $90.00 price objective (up from $69.00) on shares of West Pharmaceutical Services in a research report on Friday, May 13th.
Get your swing trade ideas at http://investorshub.advfn.com/boards/board.aspx?board_id=11403
Recent WST News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/20/2026 08:04:33 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/13/2026 08:11:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 09:06:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 07:34:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:35:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:33:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:32:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:30:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:26:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:21:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:18:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:49:31 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:26:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 04:22:22 PM
- West to Participate in Upcoming Investor Conferences • PR Newswire (US) • 04/28/2026 10:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/23/2026 08:12:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 11:11:01 AM
- West Reports First-Quarter 2026 Results • PR Newswire (US) • 04/23/2026 10:00:00 AM
- West to Host First-Quarter 2026 Conference Call • PR Newswire (US) • 04/09/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 06:17:56 PM
- West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity • PR Newswire (US) • 03/31/2026 03:46:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/12/2026 12:32:19 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/12/2026 12:31:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:33:25 PM
